alakananda dasgupta

Alakananda Dasgupta

Alakananda Dasgupta is a freelance science journalist based in New Delhi, India, who contributes to The Scientist. She is a medical doctor and a pathologist by training. In 2018, she combined her interests in science and writing and became a science writer. She has done research previously in the field of immunology and is currently writing a book on the subject.

Articles by Alakananda Dasgupta
Microscope image of A549-ACE2 lung cells coinfected with SARS-CoV-2 and a reporter vector containing a key regulatory variant of interest in the region on human chromosome 3
How Genes from Neanderthals Predispose People to Severe COVID-19
Alakananda Dasgupta | Feb 22, 2023 | 4 min read
Researchers dissect the Neanderthal-derived region on chromosome 3 that drives severe COVID-19 to zero in on the key causal variants.
Special Report
endothelium covid-19 vwf p-selectin thrombosis blood clot vasculature coronavirus sars-cov-2 pandemic
The Specter of Endothelial Injury in COVID-19
Alakananda Dasgupta | Nov 3, 2020 | 6 min read
Studies signal that damage to the endothelium—cells that cover blood vessels like wallpaper—could underpin the thrombosis and inflammation induced by coronavirus infection.
convalescent plasma covid-19 coronavirus pandemic antibodies sars-cov-2 fda emergency use authorization india randomized controlled trial
Indian Study Shows No Survival Benefit of Plasma in COVID-19
Alakananda Dasgupta | Sep 15, 2020 | 5 min read
A randomized controlled trial on the use of convalescent plasma therapy to treat coronavirus infections—the first in the world to be completed—yields disappointing results, but some doctors are not discouraged.
bradykinin kinin cascade ras covid-19 sars-cov-2 dabk cytokines macrophage edema fluid lung leaky blood vessel
Is a Bradykinin Storm Brewing in COVID-19?
Alakananda Dasgupta | Aug 26, 2020 | 5 min read
Excess of the inflammatory molecule bradykinin may explain the fluid build-up in the lungs of patients with coronavirus infections. Clinical trials of inhibitors are putting this hypothesis to the test.
bradykinin kinin cascade covid-19 sars-cov-2 coronavirus pandemic cytokine macrophage dabk ace2 ace immunology leaky blood vessel inflammation
Infographic: SARS-CoV-2 Interferes with Bradykinin Regulation
Alakananda Dasgupta | Aug 26, 2020 | 1 min read
The leaky blood vessels and lung fluid build-up in some COVID-19 patients might be explained by the virus’s corruption of an inflammation safeguard.
Special Report
ifn interferon interferon-alpha interferon-beta synairgen interferon-lambda coronavirus pandemic covid-19 sars-cov-2 innate immune response cytokine inflammation drug therapeutic preventive
Seeking an Early COVID-19 Drug, Researchers Look to Interferons
Alakananda Dasgupta | Jul 20, 2020 | 9 min read
These antiviral proteins are produced by the body as a natural defense against viral infections and synthetic interferons might help prevent or treat the beginning stages of SARS-CoV-2 infection.
neutrophil extracellular traps NETs coronavirus covid-19 pandemic sars-cov-2 innate immune response immunity pathogen elastase chromatin DNA
Neutrophil Extracellular Traps May Augur Severe COVID-19
Alakananda Dasgupta | May 28, 2020 | 6 min read
These webs of chromatin and proteins, released by immune cells to control microbial infections, could serve as a therapeutic target in coronavirus infections.
arsenicum album homeopathy coronavirus india 2019-ncov
Indian Authorities Propose Use of Homeopathy to Prevent Coronavirus
Alakananda Dasgupta | Feb 7, 2020 | 5 min read
Critics of the practice say the guidance is irresponsible and could give users a false sense of security.
university of kashmir jammu j&k india communication blackout
Science in India’s Kashmir Valley in Jeopardy
Alakananda Dasgupta | Sep 24, 2019 | 5 min read
The country’s government has imposed a communication blackout on Jammu and Kashmir, the northernmost region in India, effectively cutting off scientists and students from the rest of the world.